CD&R completes $1.65bn VWR deal

Clayton, Dubilier & Rice takes over the laboratory supplies company from pharmaceuticals group Merck, putting $450m of its own equity toward the deal.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this